4.1
药物分布：概述
体内药物的分布是一个动态过程，涉及药物在各个区域内以两个方向移动：从血流进入组织（组织吸收）和从组织返回血流（组织释放或再分布）。这个过程是被动的，主要由两个变量驱动：血流和血管外组织之间的浓度梯度以及药物穿过细胞膜的能力。
最初，血流中的游离药物有效地渗透毛细血管壁，使其进入称为细胞外液的血管外空…
分布是指药物在体内不同隔室之间的双向移动。
这是一个由血液与血管外组织之间的浓度梯度驱动的被动过程。
最初，血液中的游离药物迅速透过毛细血管壁，进入细胞外液（ECF）。
随后，它穿过组织细胞膜，到达细胞内液。
该步骤是限速步骤，依赖于两个主要因素。首先是向细胞外组织的灌注速率，这决定了药物递送至组织的速度。
第二是药物的膜通透性，它决定了药物穿过细胞膜的难易程度。
影响药物分布的其他因素包括器官或组织的大小、生理屏障以及个体差异。
分布容积反映了药物在体内分布的理论体液体积。
View the full transcript and gain access to JoVE Core videos
Q1: What is drug distribution and how does it work in the body?
Drug distribution is the two-way movement of a drug between different body compartments, driven by concentration gradients. Free drug in the blood passively permeates capillary walls and enters the extracellular fluid. From there, it crosses cell membranes to reach intracellular fluid. This process is passive and relies on the concentration difference between blood and tissues to move drugs throughout the body.
Q2: Why is crossing the cell membrane the rate-limiting step in drug distribution?
Crossing the cell membrane is the rate-limiting step because it determines how quickly a drug reaches its site of action inside cells. Two factors control this step: perfusion rate, which determines how fast the drug reaches tissue, and membrane permeability, which dictates how easily the drug crosses the cell membrane. Together, these factors govern the overall speed of drug distribution throughout the body.
Q3: How does plasma protein binding affect drug distribution?
Drugs bound to plasma proteins like albumin become inactive and cannot cross cell membranes, limiting their availability for tissue uptake. Only free, unbound drug can distribute into tissues. This binding significantly restricts how much active drug reaches target cells, making protein binding a critical factor in determining drug distribution patterns and therapeutic effectiveness.
Q4: What role do physiological barriers play in drug distribution?
Physiological barriers like the blood-brain barrier restrict passage of certain substances, protecting sensitive organs such as the brain. These barriers limit which drugs can reach specific tissues, affecting overall distribution patterns. Individual differences in barrier function and drug characteristics determine whether a drug can cross these protective boundaries to reach its target tissue.
Q5: How does tissue release occur after drug distribution?
Tissue release occurs when drug concentrations in the bloodstream decrease due to metabolism or elimination, creating a reverse concentration gradient. Drugs diffuse back from tissues into the blood, driven by this concentration difference. The tissue's affinity for the drug, presence of binding proteins, and the drug's ability to diffuse through membranes all influence the rate of tissue release.
Q6: What factors besides perfusion and permeability influence drug distribution?
Organ or tissue size impacts how much drug can be accommodated, while individual differences such as genetic variations, metabolism rates, and overall health influence distribution patterns. These factors work alongside perfusion rate and membrane permeability to determine the final distribution of a drug throughout the body and its therapeutic effectiveness.
Q7: What does volume of distribution represent in pharmacokinetics?
Volume of distribution is a hypothetical volume representing the body fluid space where a drug disperses to achieve the observed blood concentration. It quantifies the extent of drug distribution within the body and helps predict how widely a drug spreads. A larger volume of distribution indicates the drug distributes extensively into tissues, while a smaller volume suggests limited tissue penetration.